nsv5331991
- Organism: Homo sapiens
- Study:nstd200 (Abel et al. 2020)
- Variant Type:translocation
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:1
- Publication(s):Abel et al. 2020
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 92 SVs from 23 studies. See in: genome view
Overlapping variant regions from other studies: 78 SVs from 17 studies. See in: genome view
Overlapping variant regions from other studies: 9 SVs from 5 studies. See in: genome view
Overlapping variant regions from other studies: 92 SVs from 23 studies. See in: genome view
Overlapping variant regions from other studies: 78 SVs from 17 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|---|
| nsv5331991 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000001.11 | Chr1 | 28,269,645 | 28,269,645 | - |
| nsv5331991 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000017.11 | Chr17 | 27,973,031 | 27,973,031 | - |
| nsv5331991 | Remapped | Perfect | GRCh38.p12 | PATCHES | Second Pass | NW_018654706.1 | Chr1|NW_01 8654706.1 | 63,289 | 63,289 | - |
| nsv5331991 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000001.10 | Chr1 | 28,596,156 | 28,596,156 | - | ||
| nsv5331991 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000017.10 | Chr17 | 26,300,057 | 26,300,057 | - |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16414296 | interchromosomal translocation | Sequencing | Sequence alignment |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|
| nssv16414296 | Remapped | Perfect | GRCh38.p12 | Second Pass | NW_018654706.1 | Chr1|NW_01 8654706.1 | 63,289 | 63,289 | - |
| nssv16414296 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000001.11 | Chr1 | 28,269,645 | 28,269,645 | - |
| nssv16414296 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000017.11 | Chr17 | 27,973,031 | 27,973,031 | - |
| nssv16414296 | Submitted genomic | GRCh37 (hg19) | NC_000001.10 | Chr1 | 28,596,156 | 28,596,156 | - | ||
| nssv16414296 | Submitted genomic | GRCh37 (hg19) | NC_000017.10 | Chr17 | 26,300,057 | 26,300,057 | - |
No validation data were submitted for this variant
No clinical assertion data were submitted for this variant
Genotype Information
| Variant Call ID | Allele Frequency (AF) | Allele Count (AC) | Allele Number (AN) |
|---|---|---|---|
| nssv16414296 | <0.001 | 4 | 16834 |